Effect of Spinal Magnetic Stimulation on Management of Functional Constipation in Adults

May 6, 2024 updated by: Nehad Mohamed Elshatby Mahmoud, University of Alexandria
conservative management of functional constipation is a preferable method including biofeedback and spinal magnetic stimulation sessions

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Constipation varies in presentation and severity among patients and affects patients' quality of life of varied degrees depending on how it manifests and how severe it is. The prevalence of constipation in the general population is estimated to affect about 20% of the population

Spinal Magnetic Stimulation (SMS) is a non-invasive, painless neurophysiological treatment that uses extracorporeal magnetic stimulation to direct extracorporeal magnetic stimulation to the spinal nerves and deep muscles to aid bowl evacuation without the use of surgery. This noninvasive approach was created to help with micturition, expiration, and bowel function

The aim of this work is to study the efficacy of SMS and biofeedback versus biofeedback in the management of functional constipation.

Study Type

Interventional

Enrollment (Actual)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Alexandria, Egypt, 25700
        • Nehad ElShatby

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • adults patients diagnosed by Rome IV criteria as having functional constipation

Exclusion Criteria:

  • Patients younger than 18 years old.
  • Patients with irritable bowel syndrome.
  • Anal hemorrhoids or bleeding.
  • Any condition that may complicate bowel problems, such as Parkinson's disease, stroke, or traumatic brain injury.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Sham Comparator: Sham Therapy
Patients will receive 12 sessions of biofeedback-assisted pelvic floor muscle relaxation plus non-real magnetic stimulation.
  • Biofeedback pelvic floor muscle training sessions will be performed for both groups for a total of 12 sessions. Menstruating women will be temporarily withdrawn from BF sessions till end of the menses. The session will last for 30 minutes of transrectal pressure biofeedback relaxation technique. Auditory and visual feedback will be provided in addition to positive verbal reinforcement.
  • Sham SMS will be used in the Sham group using the placebo program in the magnetic stimulation machine.
  • Spinal magnetic stimulation using the Neuro-MS/D machine. It will be used in spinal magnetic stimulation group, circular coil will be used to stimulate S2,3 and 4 sacral roots. Intensities will be adjusted to 50-70 % of maximal output (2.2 Tesla), stimulation frequency will be fixed at 20 Hz, burst length = 5 seconds, inter-burst interval = 25 seconds.
Experimental: Spinal magnetic stimulation
Patients will receive 12 sessions of biofeedback-assisted pelvic floor muscle relaxation followed by real spinal magnetic stimulation.
  • Biofeedback pelvic floor muscle training sessions will be performed for both groups for a total of 12 sessions. Menstruating women will be temporarily withdrawn from BF sessions till end of the menses. The session will last for 30 minutes of transrectal pressure biofeedback relaxation technique. Auditory and visual feedback will be provided in addition to positive verbal reinforcement.
  • Sham SMS will be used in the Sham group using the placebo program in the magnetic stimulation machine.
  • Spinal magnetic stimulation using the Neuro-MS/D machine. It will be used in spinal magnetic stimulation group, circular coil will be used to stimulate S2,3 and 4 sacral roots. Intensities will be adjusted to 50-70 % of maximal output (2.2 Tesla), stimulation frequency will be fixed at 20 Hz, burst length = 5 seconds, inter-burst interval = 25 seconds.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of weekly bowel movement
Time Frame: after 15 days
Mean weekly complete spontaneous bowel movements.
after 15 days
The Bristol Stool Scale (from 1 to 5)
Time Frame: After 15 days
Stool consistency
After 15 days
Numerical rating scale (from 0 to 10)
Time Frame: After 15 days
pain assessment, zero indicates no pain, 10 indicates maximum pain degree
After 15 days
Patient Assessment of Constipation Quality of Life questionnaire
Time Frame: After 15 days
Assessment of quality of life (from 9 to 127) lower scores indicating fewer problems
After 15 days
pressure manometry
Time Frame: After 15 days
Assessment of pelvic floor power of contraction
After 15 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of weekly bowel movement
Time Frame: after one month
Mean weekly complete spontaneous bowel movements.
after one month
The Bristol Stool Scale (from 1 to 5)
Time Frame: After one month
Stool consistency
After one month
Numerical rating scale (from 0 to 10)
Time Frame: After one month
pain assessment, zero indicates no pain, 10 indicates maximum pain degree
After one month
Patient Assessment of Constipation Quality of Life questionnaire
Time Frame: After one month
Assessment of quality of life (from 9 to 127) lower scores indicating fewer problems
After one month
Pressure manometry
Time Frame: After one month
Assessment of pelvic floor power of contraction
After one month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Nehad ElShatby, MD,PhD, Alexandria University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Actual)

October 1, 2022

Study Completion (Actual)

October 1, 2022

Study Registration Dates

First Submitted

January 10, 2022

First Submitted That Met QC Criteria

January 22, 2022

First Posted (Actual)

February 2, 2022

Study Record Updates

Last Update Posted (Actual)

May 8, 2024

Last Update Submitted That Met QC Criteria

May 6, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 0305398

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All IPD will be available with the corresponding author for three years after publishing the study, and ready to be shared with other researchers

IPD Sharing Time Frame

from date of publication and 3 years after

IPD Sharing Access Criteria

Contact the corresponding author via dr.nehad@yahoo.com

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • SAP
  • ICF
  • CSR

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Functional Constipation

Clinical Trials on spinal magnetic stimulation

Subscribe